Subjective and Objective Changes in Muscle-stiffness

March 4, 2022 updated by: Steffan Wittrup Christensen, Aalborg University

The Relationship Between Subjective and Objective Changes in Muscle-stiffness

The purpose of this study is to investigate muscle stiffness in relation to delayed on-set muscle soreness following exercise and to investigate how well the change in muscle stiffness correlates with the subjective experienced degree of stiffness.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Steffan WM Christensen, PhD
  • Phone Number: +45 99408889
  • Email: stc@hst.aau.dk

Study Locations

      • Aalborg, Denmark, 9220
        • Recruiting
        • Dept. Of Health Science and Technology, Aalborg University
        • Contact:
          • Steffan W Christensen, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy participants aged 18-80
  • Able to speak, read and understand Danish and/or English

Exclusion Criteria:

  • Have performed resistance training on a regular basis during the past month
  • Experience of delayed onset muscle soreness (DOMS) during the last two weeks leading up to the first test session
  • Current use of analgesics
  • Any current neurological, musculoskeletal or mental illnesses that could interfere with the results.
  • Pregnancy
  • Lack of ability to cooperate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Participants will not perform any exercise
Experimental: Exercise
Participants will perform an exercise recommended for preventing neck and shoulder pain
Upper limb exercises using an elastic band.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle stiffness (change) - Shear wave
Time Frame: Day1,Day 2 and Day7
Muscle stiffness measured by ultrasound using shear wave elastography
Day1,Day 2 and Day7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle stiffness (change) - Self-reported
Time Frame: Day1,Day 2 and Day7
Self-reported muscle stiffness: Measured on a NRS scale (0-10), where 0 = not stiff at all, 10 is maximal stiffness
Day1,Day 2 and Day7
Muscle stiffness (change) - Myotonometry
Time Frame: Day1,Day 2 and Day7
Muscle stiffness measured by Myotonometry
Day1,Day 2 and Day7
Muscle stiffness (change)- Palpation
Time Frame: Day1,Day 2 and Day7
Muscle palpation: Reported using a 5-point Likert: 1 = very low muscle stiffness and 5 = very high muscle stiffness
Day1,Day 2 and Day7

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle thickness
Time Frame: Day1,Day 2 and Day7
Muscle thickness measured by ultrasound
Day1,Day 2 and Day7
Muscle soreness
Time Frame: Day1,Day 2 and Day7
Self-reported muscle soreness: Measured on a NRS scale (0-10), where 0 = not sore at all, 10 is maximal soreness
Day1,Day 2 and Day7
Neck disability
Time Frame: Day1,Day 2 and Day7
The NDI is questionnaire investigating neck pain and disability: Scores range from 0 to 50. Higher score represent worse disability
Day1,Day 2 and Day7
Shoulder disability
Time Frame: Day1,Day 2 and Day7
SPADI is a 13-item questionnaire investigating shoulder pain and disability: Scores range from 0 to 130. Higher score represent worse disability
Day1,Day 2 and Day7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Steffan WM Christensen, PhD, Aalborg University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2022

Primary Completion (Anticipated)

May 31, 2023

Study Completion (Anticipated)

July 31, 2023

Study Registration Dates

First Submitted

February 16, 2022

First Submitted That Met QC Criteria

March 4, 2022

First Posted (Actual)

March 15, 2022

Study Record Updates

Last Update Posted (Actual)

March 15, 2022

Last Update Submitted That Met QC Criteria

March 4, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Exercise

Subscribe